BlackRock Japan’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

BlackRock Japan’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$51K	Sell	470 -479	-50%	-$56K	﹤0.01%	981
2016 Q3	$118K	Buy	949 +930	+4,895%	+$110K	﹤0.01%	859
2016 Q2	$2K	Sell	19 -50	-72%	-$5.81K	﹤0.01%	1403
2016 Q1	$8K	Sell	69 -29	-30%	-$3.4K	﹤0.01%	1318
2015 Q4	$14K	Sell	98 -28	-22%	-$3.23K	﹤0.01%	1230
2015 Q3	$11K	Sell	126 -4,108	-97%	-$434K	﹤0.01%	1161
2015 Q2	$488K	Buy	4,234 +3,808	+894%	+$400K	﹤0.01%	788
2015 Q1	$41K	Sell	426 -220	-34%	-$16.5K	﹤0.01%	1097
2014 Q4	$43K	Sell	646 -477	-42%	-$29.6K	﹤0.01%	1121
2014 Q3	$61K	Buy	1,123 +572	+104%	+$28.2K	﹤0.01%	1023
2014 Q2	$25K	Buy	+551	New	+$22.5K	﹤0.01%	1134
2013 Q4	–	Sell	-992	Closed	-$29K	–	1473
2013 Q3	$29K	Sell	992 -1,500	-60%	-$37.4K	﹤0.01%	1195
2013 Q2	$58K	Buy	+2,492	New	+$62.9K	﹤0.01%	1070

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock Japan's CBPO Position: Q4 2016 in Review

BlackRock Japan reduced its China Biologic Products Holdings, Inc. (CBPO) stake by 50% in Q4 2016, selling an estimated $56K and leaving 470 shares worth $51K. The position accounts for ﹤0.01% of the portfolio, ranked #981.

BlackRock Japan first reported a position in CBPO in Q2 2013 and has held it in 13 quarters since. The position peaked at $488K in Q2 2015. 143 funds tracked by Wall St. Rank hold CBPO as of Q4 2016.

BlackRock Japan held 470 shares of China Biologic Products Holdings, Inc. worth $51K as of Q4 2016.
BlackRock Japan sold 479 China Biologic Products Holdings, Inc. shares in Q4 2016, an estimated $56K.
China Biologic Products Holdings, Inc. made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #981 holding.
BlackRock Japan first reported a position in China Biologic Products Holdings, Inc. in Q2 2013 and has held it in 13 quarters since.
BlackRock Japan's China Biologic Products Holdings, Inc. position peaked at $488K in Q2 2015.
143 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.